Hawaii has the lowest rates of GLP-1 medication usage, with 0.4 percent of patients on the drugs, and 3 percent of patients with obesity taking them
Phase 2 trial establishing 24.2% mean weight loss at 12mg over 48 weeks, with dose-response data across the 1mg to 12mg range
Approximately 15%, 18%, and 20% differentially expressed phosphoproteins are involved in the p53, cell cycle, and apoptosis pathways, respectively (Fig
Beginning too many changes at once makes it difficult to attribute effects to specific components
Participation in clinical trials may be possible for eligible individuals
Seek urgent medical attention (call NHS 111 or 999 in an emergency) if you develop severe abdominal pain especially pain that radiates to the back (which may indicate pancreatitis) or right upper quadrant pain with fever or jaundice (which may indicate gallbladder disease)